Has Salil Dua received payments from drug or device companies?

Yes. Drug and device makers reported $7,274 in general payments to Salil Dua across 160 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Salil Dua did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Salil Dua come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Salil Dua

Family Medicine · Lansing, MINPI 1780658625

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 60.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $4,387 and has fallen 98.3% since, to $75 in 2023. Among family medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,274in general payments, 2019–2025

Across 160 payments — averaging $45.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$4K
Sunovion Pharmaceuticals Inc.$829
GSK$491
Lilly USA, LLC$445
Pfizer$274
Amgen$147
plus $719 from 13 others

What the payments were for

Speaking & faculty fees$3,77552%
Travel & lodging$1362%
Food & beverage$3,35946%
Education$50%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	33	$4,369
Sunovion Pharmaceuticals Inc.	52	$829
GSK	17	$491
Lilly USA, LLC	19	$445
Pfizer	11	$274
Amgen	3	$147
AstraZeneca	2	$140
MDD US Operations, LLC	1	$125
Daiichi Sankyo Inc.	1	$117
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$67
Teva Pharmaceuticals USA, Inc.	4	$55
Novo Nordisk	3	$42
Takeda Pharmaceuticals U.S.A., Inc.	2	$38
Vanda Pharmaceuticals Inc.	2	$38
Biohaven Pharmaceuticals, Inc.	2	$31
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$25
Johnson & Johnson	1	$15
E.r. Squibb & Sons, L.L.C.	1	$15
Corcept Therapeutics	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,274 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan →

Other family medicine in Lansing

Farhan BhattiLansing$230K
Laurie RozekLansing$86K
Amy TrinhLansing$19K
Rosemary RoperLansing$17K
Mark SchaarLansing$16K
Loren ChudlerSouthfield$1.3M
Paul BensonBerkley$779K
Matt RosenbergJackson$550K
Steve LasaterSaint Johns$291K
Mary DagenGrand Rapids$265K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →